Differential role of CSF fatty acid binding protein 3, α-synuclein, and Alzheimer’s disease core biomarkers in Lewy body disorders and Alzheimer’s dementia
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Differential role of CSF fatty acid binding protein 3, α-synuclein, and Alzheimer’s disease core biomarkers in Lewy body disorders and Alzheimer’s dementia
Authors
Keywords
Cerebrospinal fluid, Biomarkers, Dementia, Heart fatty acid binding protein, Tau, α-Synuclein, Amyloid
Journal
Alzheimers Research & Therapy
Volume 9, Issue 1, Pages -
Publisher
Springer Nature
Online
2017-07-27
DOI
10.1186/s13195-017-0276-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Increased levels of CSF total but not oligomeric or phosphorylated forms of alpha-synuclein in patients diagnosed with probable Alzheimer’s disease
- (2017) Nour K. Majbour et al. Scientific Reports
- Preclinical amyloid pathology biomarker positivity: effects on tau pathology and neurodegeneration
- (2017) K Höglund et al. Translational Psychiatry
- CSF Levels of Heart Fatty Acid Binding Protein are Altered During Early Phases of Alzheimer's Disease
- (2017) Davide Chiasserini et al. JOURNAL OF ALZHEIMERS DISEASE
- PERFORMANCE EVALUATION OF NEW ABSORBANCE-BASED ELISAS FOR MEASURING DIFFERENT ALPHA-SYNUCLEIN (A-SYN) SPECIES IN CSF AND PLASMA
- (2016) Erik Stoops et al. Alzheimers & Dementia
- Value of cerebrospinal fluid α-synuclein species as biomarker in Parkinson's diagnosis and prognosis
- (2016) Lucilla Parnetti et al. Biomarkers in Medicine
- Performance Evaluation of an Automated ELISA System for Alzheimer’s Disease Detection in Clinical Routine
- (2016) Davide Chiasserini et al. JOURNAL OF ALZHEIMERS DISEASE
- Cerebrospinal α-synuclein in α-synuclein aggregation disorders: tau/α-synuclein ratio as potential biomarker for dementia with Lewy bodies
- (2016) Franc Llorens et al. JOURNAL OF NEUROLOGY
- Distribution and Load of Amyloid-β Pathology in Parkinson Disease and Dementia with Lewy Bodies
- (2016) Dagmar H. Hepp et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis
- (2016) Bob Olsson et al. LANCET NEUROLOGY
- Longitudinal changes in CSF alpha-synuclein species reflect Parkinson's disease progression
- (2016) Nour K. Majbour et al. MOVEMENT DISORDERS
- Tau Positron Emission Tomographic Imaging in the Lewy Body Diseases
- (2016) Stephen N. Gomperts et al. JAMA Neurology
- Amyloid PET Imaging in Lewy Body Disorders
- (2015) Paul Donaghy et al. AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY
- A panel of nine cerebrospinal fluid biomarkers may identify patients with atypical parkinsonian syndromes
- (2015) N K Magdalinou et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Validation of a quantitative cerebrospinal fluid alpha-synuclein assay in a European-wide interlaboratory study
- (2015) Niels Kruse et al. NEUROBIOLOGY OF AGING
- Cerebrospinal Fluid Patterns and the Risk of Future Dementia in Early, Incident Parkinson Disease
- (2015) David C. Bäckström et al. JAMA Neurology
- Cerebrospinal Fluid P-Tau181P: Biomarker for Improved Differential Dementia Diagnosis
- (2015) Hanne Struyfs et al. Frontiers in Neurology
- Increased CSF α-synuclein levels in Alzheimer's disease: Correlation with tau levels
- (2014) Sylvie Slaets et al. Alzheimers & Dementia
- Phosphorylated Tau-Aβ 42 Ratio as a Continuous Trait for Biomarker Discovery for Early-Stage Alzheimer’s Disease in Multiplex Immunoassay Panels of Cerebrospinal Fluid
- (2014) Oscar Harari et al. BIOLOGICAL PSYCHIATRY
- FABP3 Protein Promotes α-Synuclein Oligomerization Associated with 1-Methyl-1,2,3,6-tetrahydropiridine-induced Neurotoxicity
- (2014) Norifumi Shioda et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Does CSF p-tau181 help to discriminate Alzheimer’s disease from other dementias and mild cognitive impairment? A meta-analysis of the literature
- (2014) Wei Tang et al. JOURNAL OF NEURAL TRANSMISSION
- Tau protein, beta-amyloid1–42 and clusterin CSF levels in the differential diagnosis of Parkinsonian syndrome with dementia
- (2014) Hana Přikrylová Vranová et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria
- (2014) Bruno Dubois et al. LANCET NEUROLOGY
- Cerebrospinal fluid lysosomal enzymes and alpha-synuclein in Parkinson's disease
- (2014) Lucilla Parnetti et al. MOVEMENT DISORDERS
- CSF A 42 predicts early-onset dementia in Parkinson disease
- (2014) G. Alves et al. NEUROLOGY
- Levels of cerebrospinal fluid α-synuclein oligomers are increased in Parkinson’s disease with dementia and dementia with Lewy bodies compared to Alzheimer’s disease
- (2014) Oskar Hansson et al. Alzheimers Research & Therapy
- Differential role of CSF alpha-synuclein species, tau, and Aβ42 in Parkinson's Disease
- (2014) Lucilla Parnetti et al. Frontiers in Aging Neuroscience
- CSF α-synuclein improves diagnostic and prognostic performance of CSF tau and Aβ in Alzheimer’s disease
- (2013) Jon B. Toledo et al. ACTA NEUROPATHOLOGICA
- Heart-type fatty acid binding protein and vascular endothelial growth factor: cerebrospinal fluid biomarker candidates for Alzheimer’s disease
- (2013) Liang-Hao Guo et al. EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE
- Heart fatty acid binding protein and Aβ-associated Alzheimer’s neurodegeneration
- (2013) Rahul S Desikan et al. Molecular Neurodegeneration
- Cerebrospinal fluid biomarkers in Parkinson disease
- (2013) Lucilla Parnetti et al. Nature Reviews Neurology
- The diagnostic utility of cerebrospinal fluid alpha-synuclein analysis in dementia with Lewy bodies – A systematic review and meta-analysis
- (2013) Xuxin Lim et al. PARKINSONISM & RELATED DISORDERS
- CSF biomarkers cutoffs: the importance of coincident neuropathological diseases
- (2012) Jon B. Toledo et al. ACTA NEUROPATHOLOGICA
- Accuracy of a Panel of 5 Cerebrospinal Fluid Biomarkers in the Differential Diagnosis of Patients With Dementia and/or Parkinsonian Disorders
- (2012) Sara Hall et al. ARCHIVES OF NEUROLOGY
- The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease
- (2011) Guy M. McKhann et al. Alzheimers & Dementia
- Pathogenic protein seeding in alzheimer disease and other neurodegenerative disorders
- (2011) Mathias Jucker et al. ANNALS OF NEUROLOGY
- Interaction between pathogenic proteins in neurodegenerative disorders
- (2011) Kurt A. Jellinger JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- α-Synuclein and tau concentrations in cerebrospinal fluid of patients presenting with parkinsonism: a cohort study
- (2011) Brit Mollenhauer et al. LANCET NEUROLOGY
- Cerebrospinal fluid Tau/α-synuclein ratio in Parkinson's disease and degenerative dementias
- (2011) Lucilla Parnetti et al. MOVEMENT DISORDERS
- Cerebrospinal fluid markers for differential dementia diagnosis in a large memory clinic cohort
- (2011) N. S. M. Schoonenboom et al. NEUROLOGY
- The Epidemiology of Dementia Associated with Parkinson's Disease
- (2010) Dag Aarsland et al. BRAIN PATHOLOGY
- Heart-Type Fatty Acid Binding Protein Regulates Dopamine D2 Receptor Function in Mouse Brain
- (2010) N. Shioda et al. JOURNAL OF NEUROSCIENCE
- From model system to clinical medicine: pathophysiologic links of common proteinopathies
- (2010) Pamela J McMillan et al. Alzheimers Research & Therapy
- Cerebrospinal tau, phospho-tau, and beta-amyloid and neuropsychological functions in Parkinson's disease
- (2009) Yaroslau Compta et al. MOVEMENT DISORDERS
- Improved discrimination of autopsy-confirmed Alzheimer's disease (AD) from non-AD dementias using CSF P-tau181P
- (2009) Karen Koopman et al. NEUROCHEMISTRY INTERNATIONAL
- A consensus protocol for the standardization of cerebrospinal fluid collection and biobanking
- (2009) C. E. Teunissen et al. NEUROLOGY
- Cerebrospinal fluid α-synuclein in neurodegenerative disorders—A marker of synapse loss?
- (2008) Annika Öhrfelt et al. NEUROSCIENCE LETTERS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started